Locations
Cambridge, MA, USA · Cambridge, MA, USA
industry
Health · Medical Devices
Size
11-50 employees
Stage
Other
founded in
2021
Anumana™ is harnessing industry-leading AI and translational science to decode electrical signals from the heart as never before, empowering healthcare providers to transform patient care throughout the cardiac clinical pathway. Serious cardiovascular diseases affect millions of people worldwide, often going undiagnosed until symptoms advance and patients deteriorate. Unfortunately, these conditions can remain undiagnosed until the patient suffers a life-threatening event. Innovations enabling earlier diagnoses could address this unmet medical need and empower healthcare providers to intervene with life-saving treatments. Anumana recently acquired Neutrace and is leveraging the power of novel ECG-EGM-EMR integration for clinically valuable, actionable insights. With nference’s proprietary NSIGHTS real-world evidence generation platform, built on data from leading health systems, we combine unparalleled longitudinal structured and unstructured electronic medical record data with diagn
Something looks off?On-site & Remote